Back To FDA-Approved Treatments

Chemotherapy

Approved for: NSCLC, SCLC

Methotrexate Sodium (Trexall/ Xatmep)

Related Research News

FDA Approves Repotrectinib for Locally Advanced or Metastatic ROS1+ NSCLC

FDA Approves Repotrectinib for Locally Advanced or Metastatic ROS1+ NSCLC

Clinical Research Demonstrates Positive Impact of Genomic Testing for Patients with Non-Small Cell Lung Cancer

Clinical Research Demonstrates Positive Impact of Genomic Testing for Patients with Non-Small Cell Lung Cancer

A Multicenter Study on the Efficacy of Immunotherapy in Advanced Lung Cancer Patients

A Multicenter Study on the Efficacy of Immunotherapy in Advanced Lung Cancer Patients

Donate Online

Your donation to Lung Cancer Foundation of America will help to fund research that will find new treatments for lung cancer patients everywhere.

I want to give in honor of...

name or relation

Donation Amount

other amount